Pliant Therapeutics announced that the latest data from the Phase 1 clinical trial of its investigational drug Pln-101095 for patients with immune checkpoint inhibitor (ICI)-refractory solid tumors will be presented in a special report at the 2026 American Association for Cancer Research (AACR) Annual Meeting.
Pliant Therapeutics announced that the latest data from the Phase 1 clinical trial of its investigational drug Pln-101095 for patients with immune checkpoint inhibitor (ICI)-refractory solid tumors will be presented in a special report at the 2026 American Association for Cancer Research (AACR) Annual Meeting.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This groundbreaking study aims to evaluate the safety and preliminary efficacy of Pln-101095 in patients with advanced solid tumors, providing new potential directions for tumor immunotherapy.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
U.S. Supreme Court Dismisses Private Lawsuits Under Key Securities Law
Cointime•2026/06/11 14:37
U.S. Semiconductor Sector Gains Momentum, Intel Surges Over 10%
Cointime•2026/06/11 14:37
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$62,873.87
+1.65%
Ethereum
ETH
$1,645.49
+0.36%
Tether USDt
USDT
$0.9989
-0.03%
BNB
BNB
$599.38
+1.24%
USDC
USDC
$0.9998
+0.01%
XRP
XRP
$1.11
-0.82%
Solana
SOL
$65.32
+0.53%
TRON
TRX
$0.3209
-0.31%
Dogecoin
DOGE
$0.08493
+0.74%
Hyperliquid
HYPE
$56.64
-2.40%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now